Clinical trial
Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin (MACROS) : A Comparison of Risk Scores in Consecutive, Unselected Chest Pain Presentations With Suspected Acute Coronary Syndrome in the Era of High Sensitive Troponin
NCT02581540 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin (MACROS) : A Comparison of Risk Scores in Consecutive, Unselected Chest Pain Presentations With Suspected Acute Coronary Syndrome in the Era of High Sensitive Troponin
- Lead sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- July 31, 2016
- Enrollment
- 3,054 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, angina pectoris, angina, unstable, cardiovascular diseases, chest pain, chest pain atypical syndrome, heart attack, heart diseases, myocardial infarction, myocardial ischemia